|
End-of-day quote
Shenzhen S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 3.350 CNY | -1.76% |
|
-7.71% | -25.88% |
| Market Cap | 2.29B 344M 308M 284M 257M 480M 32.69B 489M 3.38B 1.36B 17.2B 1.29B 1.26B 54.24B | P/E 2024 |
-2.74x | P/E 2025 | -7.41x |
|---|---|---|---|---|---|
| Enterprise Value | 2.7B 406M 364M 335M 303M 567M 38.57B 577M 3.99B 1.6B 20.29B 1.52B 1.49B 63.98B | EV / Sales 2024 |
2.87x | EV / Sales 2025 | 3.89x |
| Free-Float |
54.4% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.76% | ||
| 1 week | -7.71% | ||
| Current month | -19.47% | ||
| 1 month | -19.47% | ||
| 3 months | -4.29% | ||
| 6 months | -28.27% | ||
| Current year | -25.88% |
| 1 week | 3.31 | 3.64 | |
| 1 month | 3.31 | 4.24 | |
| Current year | 3.18 | 6.24 | |
| 1 year | 3.18 | 6.24 | |
| 3 years | 1.24 | 6.24 | |
| 5 years | 1.24 | 7.83 | |
| 10 years | 1.24 | 31.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhi Qiang Zhang
CEO | Chief Executive Officer | 59 | 01/03/2010 |
| Director of Finance/CFO | 52 | 21/04/2023 | |
Wei He
CTO | Chief Tech/Sci/R&D Officer | 49 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Hong Lan Zhang
BRD | Director/Board Member | 54 | 27/09/2019 |
Xiao You Zhang
BRD | Director/Board Member | 74 | - |
You Guang Li
BRD | Director/Board Member | 69 | 27/09/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.76% | -7.71% | -30.64% | -4.56% | 344M | ||
| +3.19% | +11.31% | +67.86% | +150.58% | 1,263B | ||
| -0.73% | +3.56% | +44.51% | +85.81% | 658B | ||
| +1.41% | +3.24% | +29.22% | +107.83% | 521B | ||
| +0.42% | +3.20% | +54.15% | +67.18% | 391B | ||
| +2.18% | +2.93% | +73.30% | +45.62% | 369B | ||
| +1.12% | +4.52% | +35.30% | +58.08% | 307B | ||
| +6.96% | +8.86% | +11.27% | +36.62% | 290B | ||
| +1.15% | +6.09% | +59.59% | +77.06% | 252B | ||
| +3.06% | +9.38% | +44.11% | +119.47% | 212B | ||
| Average | +1.38% | +4.64% | +38.87% | +74.37% | 426.23B | |
| Weighted average by Cap. | +1.19% | +6.60% | +50.87% | +98.31% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.2B 180M 161M 148M 134M 251M 17.06B 255M 1.76B 708M 8.97B 674M 660M 28.3B | 900M 135M 121M 111M 101M 189M 12.84B 192M 1.33B 533M 6.75B 507M 497M 21.3B |
| Net income | -650M -97.68M -87.48M -80.47M -72.91M -136M -9.27B -139M -960M -385M -4.88B -367M -359M -15.39B | -420M -63.06M -56.47M -51.95M -47.07M -87.98M -5.99B -89.63M -619M -249M -3.15B -237M -232M -9.93B |
| Net Debt | 1.66B 250M 224M 206M 186M 348M 23.7B 355M 2.45B 984M 12.47B 937M 917M 39.32B | 412M 61.84M 55.39M 50.95M 46.16M 86.29M 5.87B 87.9M 608M 244M 3.09B 232M 227M 9.74B |
Employees
979
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | CN¥3.350 | -1.76% | 18,021,501 |
| 29/10/26 | CN¥3.410 | -2.29% | 11,443,300 |
| 28/10/26 | CN¥3.490 | +1.16% | 12,611,800 |
| 27/10/26 | CN¥3.450 | -3.90% | 13,538,000 |
| 26/10/26 | CN¥3.590 | -1.10% | 12,420,100 |
- Stock Market
- Stocks
- 002742 Stock
Select your edition
All financial news and data tailored to specific country editions
















